| Abstrakt: |
Keywords for this news article include: Shanghai, People's Republic of China, Asia, Antibiotics, Antineoplastics, Apoptosis, Cardiology, Cardiomyocyte, Cardiovascular Diseases and Conditions, Cellular Physiology, Chronic Heart Failure, Doxorubicin Therapy, Drugs and Therapies, Health and Medicine, Heart Attack, Heart Disease, Heart Disorders and Diseases, Heart Failure, Pharmaceuticals, Shanghai University of Traditional Chinese Medicine. Keywords: Shanghai; People's Republic of China; Asia; Antibiotics; Antineoplastics; Apoptosis; Cardiology; Cardiomyocyte; Cardiovascular Diseases and Conditions; Cellular Physiology; Chronic Heart Failure; Doxorubicin Therapy; Drugs and Therapies; Health and Medicine; Heart Attack; Heart Disease; Heart Disorders and Diseases; Heart Failure; Pharmaceuticals EN Shanghai People's Republic of China Asia Antibiotics Antineoplastics Apoptosis Cardiology Cardiomyocyte Cardiovascular Diseases and Conditions Cellular Physiology Chronic Heart Failure Doxorubicin Therapy Drugs and Therapies Health and Medicine Heart Attack Heart Disease Heart Disorders and Diseases Heart Failure Pharmaceuticals 286 286 1 04/17/23 20230421 NES 230421 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Heart Disorders and Diseases - Chronic Heart Failure are presented in a new report. Shanghai, People's Republic of China, Asia, Antibiotics, Antineoplastics, Apoptosis, Cardiology, Cardiomyocyte, Cardiovascular Diseases and Conditions, Cellular Physiology, Chronic Heart Failure, Doxorubicin Therapy, Drugs and Therapies, Health and Medicine, Heart Attack, Heart Disease, Heart Disorders and Diseases, Heart Failure, Pharmaceuticals. [Extracted from the article] |
